Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of ...

Shares of Silence Therapeutics PLC Sponsored ADR (SLN) have gained 34.4% over the past four weeks to close the last trading session at $5.78, but there could still be a solid upside left in the stock ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The management of axillary lymph nodes in breast cancer is continually evolving. Recent data now support omitting axillary lymph node dissection (ALND) in most patients with metastases in up to two ...

Silence Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest SLN financial statements, income statements and financial ratios.

BBC ONE today (Tuesday 26 March) unveiled a new, energetic and vibrant on-screen look which puts it firmly in step with contemporary life. The new channel idents explore the universal theme of rhythm, ...

Imagine our campus as a place where all its members make an effort—in how they live, work, and study—to adopt and spread more sustainable habits. The Sustainability Liaisons Network (SLN) are cohorts ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...